Frontotemporal dementia: from genetics to therapeutic approaches

References

• Neary D, Brun A, Englund B, et al. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester groups. J Neurol Neurosurg Psychiatry. 1994;57:416–418. doi: 10.1136/jnnp.57.4.416
   PubMed Web of Science ®Google Scholar
• Moore KM, Nicholas J, Grossman M, et al. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. Lancet Neurol. 2020;19:145–156. doi: 10.1016/S1474-4422(19)30394-1
   PubMed Web of Science ®Google Scholar
• Snowden JS. Changing perspectives on frontotemporal dementia: a review. J Neuropsychol. 2023;17:211–234. doi: 10.1111/jnp.12297
   PubMed Web of Science ®Google Scholar
• Gustafson L. Frontal lobe degeneration of non-Alzheimer type. II. Clinical picture and differential diagnosis. Arch Gerontol Geriatr. 1987;6:209–223. doi: 10.1016/0167-4943(87)90022-7
   PubMed Web of Science ®Google Scholar
• Miller BL, Cummings JL, Villanueva-Meyer J, et al. Frontal lobe degeneration: clinical, neuropsychological, and SPECT characteristics. Neurology. 1991;41(9):1374–1374. doi: 10.1212/wnl.41.9.1374
   PubMed Web of Science ®Google Scholar
• Neary D, Snowden JS, Gustafson L, et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology. 1998;51(6):1546–1554. doi: 10.1212/wnl.51.6.1546
   PubMed Web of Science ®Google Scholar
• Thompson SA, Patterson K, Hodges JR. Left/Right asymmetry of atrophy in semantic dementia: behavioral-cognitive implications. Neurology. 2003;61(9):1196–1203. doi: 10.1212/01.wnl.0000091868.28557.b8
   PubMed Web of Science ®Google Scholar
• Chan D, Anderson V, Pijnenburg Y, et al. The clinical profile of right temporal lobe atrophy. Brain. 2009;132(5):1287–1298. doi: 10.1093/brain/awp037
   PubMedGoogle Scholar
• Erkoyun HU, Groot C, Heilbron R, et al. A clinical-radiological framework of the right temporal variant of frontotemporal dementia. Brain. 2020;143(9):2831–2843. doi: 10.1093/brain/awaa225
   PubMedGoogle Scholar
• Ferrari R, Kapogiannis D, Huey E, et al. FTD and ALS: a tale of two diseases. Curr Alzheimer Res. 2011;8(3):273–294. doi: 10.2174/156720511795563700
   PubMed Web of Science ®Google Scholar
• Shi J, Shaw CL, Du Plessis D, et al. Histopathological changes underlying frontotemporal lobar degeneration with clinicopathological correlation. Acta Neuropathol. 2005;110(5):501–512. doi: 10.1007/s00401-005-1079-4
   PubMed Web of Science ®Google Scholar
• Brooks BR, Miller RG, Swash M, et al. El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis. Amyotroph Lateral Scler Other Motor Neuron Disord. 2000;1:293–299. doi: 10.1080/146608200300079536
   PubMed Web of Science ®Google Scholar
• Neumann M, Sampathu DM, Kwong LK, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130–133. doi: 10.1126/science.1134108
   PubMed Web of Science ®Google Scholar
• Mackenzie IRA. The neuropathology of FTD associated with ALS. Alzheimer Disease & Associated Disorders. 2007;21(4):S44–S49. doi: 10.1097/WAD.0b013e31815c3486
   PubMed Web of Science ®Google Scholar
• Mackenzie IRA, Neumann M. Molecular neuropathology of frontotemporal dementia: insights into disease mechanisms from postmortem studies. Journal Of Neurochemistry. 2016;138 Suppl 1(S1):54–70. doi: 10.1111/jnc.13588
   PubMedGoogle Scholar
• Mann DMA, Snowden JS. Frontotemporal lobar degeneration: Pathogenesis, pathology and pathways to phenotype. Brain Pathol. 2017;27:723–736. doi: 10.1111/bpa.12486
   PubMed Web of Science ®Google Scholar
• Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature. 2006;442(7105):916–919. doi: 10.1038/nature05016
   PubMed Web of Science ®Google Scholar
• DeJesus-Hernandez M, Mackenzie IR, Boeve BF, et al. Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS. Neuron [Internet]. 2011 [cited 2023 Dec 21];72(2):245–256. Available from. 10.1016/j.neuron.2011.09.011
   PubMed Web of Science ®Google Scholar
• Logroscino G, Piccininni M, Graff C, et al. Incidence of syndromes associated with frontotemporal lobar degeneration in 9 European countries. JAMA Neurol. 2023 Mar 1;80(3):279–286. doi: 10.1001/jamaneurol.2022.5128
   PubMed Web of Science ®Google Scholar
• Hutton M, Lendon CL, Rizzu P, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998;393(6686):702–705. doi: 10.1038/31508
   PubMed Web of Science ®Google Scholar
• Renton AE, Majounie E, Waite A, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257–268. doi: 10.1016/j.neuron.2011.09.011
   PubMed Web of Science ®Google Scholar
• Greaves CV, Rohrer JD. An update on genetic frontotemporal dementia. J Neurol. 2019;266(8):2075–2086. doi: 10.1007/s00415-019-09363-4
   PubMed Web of Science ®Google Scholar
• • Pick A. Uber die Beziehungen der senilen Hirnatrophie zur Aphasie. Prag Med Wchnschr. 1892;17:165–167.
   Google Scholar
• • Mesulam M‐. Slowly progressive aphasia without generalized dementia. Ann Neurol. 1982;11(6):592–598. doi: 10.1002/ana.410110607
   PubMed Web of Science ®Google Scholar
• • Pick A. Zur Symptomatologie der linksseitigen Schläfenlappena-trophie. Monatsschr Psychiatr Neurol. 1904;16:378–388. doi: 10.1159/000219215.
   Google Scholar
• Alzheimer A. über eigenartige Krankheitsfälle des späteren Alters. Zeitschrift für die gesamte Neurologie und Psychiatrie. 1911;4:356–385. doi: 10.1007/BF02866241
   Google Scholar
• Onari K, Spatz H. Anatomische Beiträge zur Lehre von der Pickschen umschriebenen Großhirnrinden-Atrophie (“Picksche Krankheit“). Arbeiten aus der Deutschen Forschungsanstalt für Psychiatrie in München (Kaiser-Wilhelm-Institut). 1926;p. 546–587. doi: 10.1007/978-3-642-49740-7_24
   Google Scholar
• Gans A. Betrachtungen über art und ausbreitung des krankhaiten prozesses in einem fall von pickscher atrophie des stirnhirns. Zeitschrift für die gesamte Neurologie und Psychiatrie. 1923;80:10–28. doi: 10.1007/BF02866679
   Google Scholar
• Horoupian DS, Thal L, Katzman R, et al. Dementia and motor neuron disease: morphometric, biochemical, and Golgi studies. Ann Neurol. 1984;16:305–313. doi: 10.1002/ana.410160306
   PubMed Web of Science ®Google Scholar
• Constantinjdis J, Richard J, Tissot R. Pick’s disease. Histological and clinical correlations. Eur Neurol. 1974;11(4):208–217. doi: 10.1159/000114320
   PubMed Web of Science ®Google Scholar
• Brun A. Frontal lobe degeneration of non-Alzheimer type. I. Neuropathology. Arch Gerontol Geriatr. 1987;6(3):193–208. doi: 10.1016/0167-4943(87)90021-5
   PubMed Web of Science ®Google Scholar
• Mann DMA, South PW, Snowden JS, et al. Dementia of frontal lobe type: neuropathology and immunohistochemistry. J Neurol Neurosurg Psychiatry. 1993;56:605–614. doi: 10.1136/jnnp.56.6.605
   PubMed Web of Science ®Google Scholar
• Shany-Ur T, Rankin KP. Personality and social cognition in neurodegenerative disease. Curr Opin Neurol. 2011;24:550–555. doi: 10.1097/WCO.0b013e32834cd42a
   PubMed Web of Science ®Google Scholar
• Snowden JS, Neary D, Mann DMA. Frontotemporal dementia. Br J Psychiatry. 2002;180(2):140–143. doi: 10.1192/bjp.180.2.140
   PubMed Web of Science ®Google Scholar
• Neary D, Snowden J, Mann D. Frontotemporal dementia. Lancet Neurol. 2005;4:771–780. doi: 10.1016/S1474-4422(05)70223-4
   PubMed Web of Science ®Google Scholar
• Fenoglio C, Scarpini E, Galimberti D. Epigenetic regulatory modifications in genetic and sporadic frontotemporal dementia. Expert Rev Neurother. 2018;18:469–475. doi: 10.1080/14737175.2018.1481389
   PubMed Web of Science ®Google Scholar
• Snowden JS, Rollinson S, Thompson JC, et al. Distinct clinical and pathological characteristics of frontotemporal dementia associated with C9ORF72 mutations. Brain. 2012;135(3):693–708. doi: 10.1093/brain/awr355
   PubMed Web of Science ®Google Scholar
• Devenney EM, Ahmed RM, Halliday G, et al. Psychiatric disorders in C9orf72 kindreds: study of 1,414 family members. Neurology. 2018;91(16):E1498–E1507. doi: 10.1212/WNL.0000000000006344
   PubMed Web of Science ®Google Scholar
• Assal F, Cummings JL. Neuropsychiatric symptoms in the dementias. Curr Opin Neurol. 2002;15:445–450. doi: 10.1097/00019052-200208000-00007
   PubMed Web of Science ®Google Scholar
• Gorno-Tempini ML, Hillis AE, Weintraub S, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76(11):1006–1014. **: doi: 10.1212/WNL.0b013e31821103e6
   PubMed Web of Science ®Google Scholar
• Rascovsky K, Hodges JR, Knopman D, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(9):2456–2477. doi: 10.1093/brain/awr179
   PubMed Web of Science ®Google Scholar
• Harris JM, Gall C, Thompson JC, et al. Classification and pathology of primary progressive aphasia. Neurology. 2013;81(21):1832–1839. doi: 10.1212/01.wnl.0000436070.28137.7b
   PubMed Web of Science ®Google Scholar
• MacKenzie IRA, Neumann M, Bigio EH, et al. Nomenclature and nosology for neuropathologic subtypes of frontotemporal lobar degeneration: an update. Acta Neuropathol. 2010;119(1):1–4. doi: 10.1007/s00401-009-0612-2
   PubMed Web of Science ®Google Scholar
• Mackenzie IRA, Neumann M, Baborie A, et al. A harmonized classification system for FTLD-TDP pathology. Acta Neuropathol. 2011;122(1):111–113. doi: 10.1007/s00401-011-0845-8
   PubMed Web of Science ®Google Scholar
• Kovacs GG. Invited review: neuropathology of tauopathies: principles and practice. Neuropathol Appl Neurobiol. 2015;41(1):3–23. doi: 10.1111/nan.12208
   PubMed Web of Science ®Google Scholar
• Whitwell JL. FTD spectrum: neuroimaging across the FTD spectrum. Prog Mol Biol Transl Sci. 2019;165:187–223. 10.1016/bs.pmbts.2019.05.009.
   PubMed Web of Science ®Google Scholar
• Ranasinghe KG, Rankin KP, Pressman PS, et al. Distinct subtypes of behavioral variant frontotemporal dementia based on patterns of network degeneration. JAMA Neurol. 2016;73(9):1078–1088. doi: 10.1001/jamaneurol.2016.2016
   PubMed Web of Science ®Google Scholar
• Josephs KA, Whitwell JL, Weigand SD, et al. Predicting functional decline in behavioural variant frontotemporal dementia. Brain. 2011;134(2):432–448. doi: 10.1093/brain/awq348
   PubMedGoogle Scholar
• Borroni B, Cosseddu M, Pilotto A, et al. Early stage of behavioral variant frontotemporal dementia: clinical and neuroimaging correlates. Neurobiol Aging. 2015;36:3108–3115. doi: 10.1016/j.neurobiolaging.2015.07.019
   PubMed Web of Science ®Google Scholar
• Rohrer JD, Warren JD, Modat M, et al. Patterns of cortical thinning in the language variants of frontotemporal lobar degeneration. Neurology. 2009 [cited 2023 Dec 28];72(18):1562–1569. doi: 10.1212/WNL.0b013e3181a4124e
   PubMed Web of Science ®Google Scholar
• Rohrer JD. Structural brain imaging in frontotemporal dementia. Biochim Biophys Acta. 2012;1822:325–332. doi: 10.1016/j.bbadis.2011.07.014
   PubMed Web of Science ®Google Scholar
• Ahmed RM, Bocchetta M, Todd EG, et al. Tackling clinical heterogeneity across the amyotrophic lateral sclerosis-frontotemporal dementia spectrum using a transdiagnostic approach. Brain Commun. 2021 Oct 23;3(4):fcab257. doi: 10.1093/braincomms/fcab257
   PubMedGoogle Scholar
• Zamboni G, Huey ED, Krueger F, et al. Apathy and disinhibition in frontotemporal dementia: insights into their neural correlates. Neurology. 2008;71(10):736–742. doi: 10.1212/01.wnl.0000324920.96835.95
   PubMed Web of Science ®Google Scholar
• Le Ber I, Guedj E, Gabelle A, et al. Demographic, neurological and behavioural characteristics and brain perfusion SPECT in frontal variant of frontotemporal dementia. Brain. 2006;129(11):3051–3065. doi: 10.1093/brain/awl288
   PubMedGoogle Scholar
• Whitwell JL, Josephs KA. Neuroimaging in frontotemporal lobar degeneration—predicting molecular pathology. Nat Rev Neurol. 2012;8(3):131–142. doi: 10.1038/nrneurol.2012.7
   PubMed Web of Science ®Google Scholar
• Josephs KA, Whitwell JL, Knopman DS, et al. Two distinct subtypes of right temporal variant frontotemporal dementia. Neurology. 2009;73:1443–1450. 10.1212/WNL.0b013e3181bf9945.
   PubMed Web of Science ®Google Scholar
• Bertoux M, Flanagan EC, Hobbs M, et al. Structural anatomical investigation of long-term memory deficit in behavioral frontotemporal dementia. J Alzheimers Dis. 2018;62(4):1887–1900. doi: 10.3233/JAD-170771
   PubMed Web of Science ®Google Scholar
• Hornberger M, Piguet O. Episodic memory in frontotemporal dementia: a critical review. Brain. 2012 Mar;135(Pt 3):678–692. doi: 10.1093/brain/aws011. PMID: 22366790.
   PubMedGoogle Scholar
• Wilson NA, Ramanan S, Roquet D, et al. Scene construction impairments in frontotemporal dementia: evidence for a primary hippocampal contribution. Neuropsychologia. 2020 Feb 3;137:107327.10.1016/j.neuropsychologia.2019.107327
   PubMed Web of Science ®Google Scholar
• Wilson NA, Ahmed RM, Hodges JR, et al. Constructing the social world: impaired capacity for social simulation in dementia. Cognition. 2020 Sep;202:104321. doi: 10.1016/j.cognition.2020.104321
   PubMed Web of Science ®Google Scholar
• Ratnavalli E, Brayne C, Dawson K, et al. The prevalence of frontotemporal dementia. Neurology. 2002;58(11):1615–1621. doi: 10.1212/wnl.58.11.1615
   PubMed Web of Science ®Google Scholar
• Bird T, Knopman D, VanSwieten J, et al. Epidemiology and genetics of frontotemporal dementia/Pick’s disease. Ann Neurol. 2003;Suppl 54(S5):S29–S31. doi: 10.1002/ana.10572
   Google Scholar
• Grossman M, Seeley WW, Boxer AL, et al. Frontotemporal lobar degeneration. Nat Rev Dis Primers. 2023 Aug 10;9(1):40. doi: 10.1038/s41572-023-00447-0
   PubMed Web of Science ®Google Scholar
• Goldman JS, Farmer JM, Wood EM, et al. Comparison of family histories in FTLD subtypes and related tauopathies. Neurology. 2005;65(11):1817–1819. doi: 10.1212/01.wnl.0000187068.92184.63
   PubMed Web of Science ®Google Scholar
• Borroni B, Bonvicini C, Galimberti D, et al. Founder effect and estimation of the age of the progranulin Thr272fs mutation in 14 Italian pedigrees with frontotemporal lobar degeneration. Neurobiology Of Aging. 2011;32(3):.e555.1–.e555.8. doi: 10.1016/j.neurobiolaging.2010.08.009
   Web of Science ®Google Scholar
• Pickering-Brown SM, Baker M, Nonaka T, et al. Frontotemporal dementia with Pick-type histology associated with Q336R mutation in the tau gene. Brain. 2004;127(6):1415–1426. doi: 10.1093/brain/awh147
   PubMedGoogle Scholar
• Heuer HW, Wang P, Rascovsky K, et al. Comparison of sporadic and familial behavioral variant frontotemporal dementia (FTD) in a North American cohort. Alzheimers Dement. 2020;16:60–70. doi: 10.1002/alz.12046
   PubMed Web of Science ®Google Scholar
• Lynch T, Sano M, Marder KS, et al. Clinical characteristics of a family with chromosome 17-linked disinhibition-dementia-parkinsonism-amyotrophy complex. Neurology. 1994;44(10):1878–1878. doi: 10.1212/wnl.44.10.1878
   PubMed Web of Science ®Google Scholar
• Wang Y, Mandelkow E. Tau in physiology and pathology. Nat Rev Neurosci. 2016;17(1):22–35. doi: 10.1038/nrn.2015.1
   PubMed Web of Science ®Google Scholar
• Lines G, Casey JM, Preza E, et al. Modelling frontotemporal dementia using patient-derived induced pluripotent stem cells. Mol Cell Neurosci. 2020;109. doi: 10.1016/j.mcn.2020.103553
   PubMed Web of Science ®Google Scholar
• Gomez-Suaga P, Mórotz GM, Markovinovic A, et al. Disruption of ER-mitochondria tethering and signalling in C9orf72-associated amyotrophic lateral sclerosis and frontotemporal dementia. Aging Cell. 2022;21. doi: 10.1111/acel.13549
   PubMed Web of Science ®Google Scholar
• Sanders DW, Kaufman SK, DeVos SL, et al. Distinct tau prion strains propagate in cells and mice and define different tauopathies. Neuron. 2014;82(6):1271–1288. doi: 10.1016/j.neuron.2014.04.047
   PubMed Web of Science ®Google Scholar
• Shi Y, Zhang W, Yang Y, et al. Structure-based classification of tauopathies. Nature. 2021;598(7880):359–363. doi: 10.1038/s41586-021-03911-7
   PubMed Web of Science ®Google Scholar
• Narasimhan S, Guo JL, Changolkar L, et al. Pathological tau strains from human brains recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain. J Neurosci. 2017;37(47):11406–11423. doi: 10.1523/JNEUROSCI.1230-17.2017
   PubMed Web of Science ®Google Scholar
• Yokoyama JS, Karch CM, Fan CC, et al. Shared genetic risk between corticobasal degeneration, progressive supranuclear palsy, and frontotemporal dementia. Acta Neuropathol. 2017;133(5):825–837. doi: 10.1007/s00401-017-1693-y
   PubMed Web of Science ®Google Scholar
• Snowden JS, Adams J, Harris J, et al. Distinct clinical and pathological phenotypes in frontotemporal dementia associated with MAPT, PGRN and C9orf72 mutations. Amyotroph Lateral Scler Frontotemporal Degener. 2015;16:497–505. doi: 10.3109/21678421.2015.1074700
   PubMed Web of Science ®Google Scholar
• Cruts M, Gijselinck I, Van Der Zee J, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006;442(7105):920–924. doi: 10.1038/nature05017
   PubMed Web of Science ®Google Scholar
• Paushter DH, Du H, Feng T, et al. The lysosomal function of progranulin, a guardian against neurodegeneration. Acta Neuropathol. 2018;136(1):1–17. doi: 10.1007/s00401-018-1861-8
   PubMed Web of Science ®Google Scholar
• Yu CE, Bird TD, Bekris LM, et al. The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch Neurol. 2010;67(2):161–170. doi: 10.1001/archneurol.2009.328
   PubMedGoogle Scholar
• Mole SE. The genetic spectrum of human neuronal ceroid-lipofuscinoses. Brain Pathol. 2004;14:70–76. doi: 10.1111/j.1750-3639.2004.tb00500.x
   PubMed Web of Science ®Google Scholar
• McGoldrick P, Zhang M, van Blitterswijk M, et al. Unaffected mosaic C9orf72 case: RNA foci, dipeptide proteins, but upregulated C9orf72 expression. Neurology. 2018;90(4):e323–e331. doi: 10.1212/WNL.0000000000004865
   PubMed Web of Science ®Google Scholar
• Smeyers J, Banchi EG, Latouche M. C9ORF72: what it is, what it does, and why it matters. Front Cell Neurosci. 2021;15. doi: 10.3389/fncel.2021.661447
   PubMed Web of Science ®Google Scholar
• Balendra R, Isaacs AM. C9orf72-mediated ALS and FTD: multiple pathways to disease. Nat Rev Neurol. 2018;14(9):544–558. doi: 10.1038/s41582-018-0047-2
   PubMed Web of Science ®Google Scholar
• Meijboom KE, Abdallah A, Fordham NP, et al. CRISPR/Cas9-mediated excision of ALS/FTD-causing hexanucleotide repeat expansion in C9ORF72 rescues major disease mechanisms in vivo and in vitro. Nat Commun. 2022;13(1):1–17. doi: 10.1038/s41467-022-33332-7
   PubMed Web of Science ®Google Scholar
• Kirola L, Mukherjee A, Mutsuddi M. Recent updates on the genetics of amyotrophic lateral sclerosis and frontotemporal dementia. Mol Neurobiol. 2022;59(9):5673–5694. doi: 10.1007/s12035-022-02934-z
   PubMed Web of Science ®Google Scholar
• Van Der Ende EL, Jackson JL, White A, et al. Unravelling the clinical spectrum and the role of repeat length in C9ORF72 repeat expansions. J Neurol Neurosurg Psychiatry. 2021;92(5):502–509. doi: 10.1136/jnnp-2020-325377
   PubMed Web of Science ®Google Scholar
• Roberson ED. Mouse models of frontotemporal dementia. Ann Neurol. 2012 Dec;72(6):837–849. doi: 10.1002/ana.23722
   PubMed Web of Science ®Google Scholar
• Ahmed RM, Irish M, van Eersel J, et al. Mouse models of frontotemporal dementia: a comparison of phenotypes with clinical symptomatology. Neurosci Biobehav Rev. 2017 Mar;74:(Pt A):126–138.
   PubMedGoogle Scholar
• Dawson TM, Golde TE, Lagier-Tourenne C. Animal models of neurodegenerative diseases. Nat Neurosci. 2018 Oct;21(10):1370–1379. doi: 10.1038/s41593-018-0236-8
   PubMed Web of Science ®Google Scholar
• Rohrer JD, Nicholas JM, Cash DM, et al. Presymptomatic cognitive and neuroanatomical changes in genetic frontotemporal dementia in the genetic frontotemporal dementia initiative (GENFI) study: a cross-sectional analysis. Lancet Neurol. 2015;14:253–262. doi: 10.1016/S1474-4422(14)70324-2
   PubMed Web of Science ®Google Scholar
• Galimberti D, Fumagalli GG, Fenoglio C, et al. Genetic FTD initiative (GENFI). Progranulin plasma levels predict the presence of GRN mutations in asymptomatic subjects and do not correlate with brain atrophy: results from the GENFI study. Neurobiol Aging. 2018;62:.e245.9–.e245.12. doi: 10.1016/j.neurobiolaging.2017.10.016
   Web of Science ®Google Scholar
• Kurnellas M, Mitra A, Schwabe T, et al. Latozinemab, a novel progranulin-elevating therapy for frontotemporal dementia. J Transl Med. 2023;21(1):1–18. doi: 10.1186/s12967-023-04251-y
   PubMed Web of Science ®Google Scholar
• Ward M, Carter LP, Huang JY, et al. Phase 1 study of latozinemab in progranulin-associated frontotemporal dementia. Alzheimers Dement (N Y). 2024;10(1):e12452. doi: 10.1002/trc2.12452
   PubMedGoogle Scholar
• Youn BS, Bang SI, Klöting N, et al. Serum progranulin concentrations may be associated with macrophage infiltration into omental adipose tissue. Diabetes. 2009 Mar;58(3):627–636. doi: 10.2337/db08-1147
   PubMed Web of Science ®Google Scholar
• Vesper Bio. Available from: https://www.vesperbio.com/
   Google Scholar
• Hinderer C, Miller R, Dyer C, et al. Adeno-associated virus serotype 1-based gene therapy for FTD caused by GRN mutations. Ann Clin Transl Neurol. 2020;7(10):1843–1853. doi: 10.1002/acn3.51165
   PubMed Web of Science ®Google Scholar
• Kariolis MS, Wells RC, Getz JA, et al. Brain delivery of therapeutic proteins using an Fc fragment blood-brain barrier transport vehicle in mice and monkeys. Sci Transl Med. 2020;12. doi: 10.1126/scitranslmed.aay1359
   Web of Science ®Google Scholar
• Passage Bio, Inc. - Passage bio announces promising initial data from phase 1/2 clinical trial of PBFT02 in FTD-GRN and updated strategic priorities. Available from: https://www.passagebio.com/investors-and-news/press-releases-and-statements/news-details/2023/Passage-Bio-Announces-Promising-Initial-Data-From-Phase-12-Clinical-Trial-of-PBFT02-in-FTD-GRN-and-Updated-Strategic-Priorities/default.aspx
   Google Scholar
• Logan T, Simon MJ, Rana A, et al. Rescue of a lysosomal storage disorder caused by grn loss of function with a brain penetrant progranulin biologic. Cell. 2021;184(18):4651–4668.e25. doi: 10.1016/j.cell.2021.08.002
   PubMed Web of Science ®Google Scholar
• Prevail. AAV-based gene therapy. Available from: https://www.prevailtherapeutics.com/
   Google Scholar
• AviadoBio. Available from: https://aviadobio.com/en/
   Google Scholar
• Haeusler AR, Donnelly CJ, Rothstein JD. The expanding biology of the C9orf72 nucleotide repeat expansion in neurodegenerative disease. Nat Rev Neurosci. 2016 Jun;17(6):383–395. doi: 10.1038/nrn.2016.38
   PubMed Web of Science ®Google Scholar
• Mori K, Weng SM, Arzberger T, et al. The C9orf72 GGGGCC repeat is translated into aggregating dipeptide-repeat proteins in FTLD/ALS. Science. 2013 Mar 15;339(6125):1335–1338. doi: 10.1126/science.1232927
   PubMed Web of Science ®Google Scholar
• Gao FB, Richter JD, Cleveland DW. Rethinking unconventional translation in neurodegeneration. Cell. 2017 Nov 16;171(5):994–1000. doi: 10.1016/j.cell.2017.10.042
   PubMed Web of Science ®Google Scholar
• Wave life Sciences.Available from: https://ir.wavelifesciences.com/news-releases/news-release-details/wave-life-sciences-announces-topline-results-Phase-1b2a-focus-c9
   Google Scholar
• Li W, Jin Y, Prazak L, et al. Transposable elements in TDP-43-mediated neurodegenerative disorders. PLoS One. 2012;7(9):e44099. doi: 10.1371/journal.pone.0044099
   PubMed Web of Science ®Google Scholar
• Liu EY, Russ J, Cali CP, et al. Loss of Nuclear TDP-43 Is Associated with decondensation of LINE retrotransposons. Cell Reports. 2019;27(5):1409–1421.e6. doi: 10.1016/j.celrep.2019.04.003
   PubMed Web of Science ®Google Scholar
• Rodriguez-Martin B, Alvarez EG, Baez-Ortega A, et al. Pan-cancer analysis of whole genomes identifies driver rearrangements promoted by LINE-1 retrotransposition. Nat Genet. 2020;52(3):306–319. doi: 10.1038/s41588-019-0562-0
   PubMed Web of Science ®Google Scholar
• Transposon Therapeutics, Inc. Available from: https://www.transposonrx.com/
   Google Scholar
• Barker MS, Gottesman RT, Manoochehri M, et al. Proposed research criteria for prodromal behavioural variant frontotemporal dementia. Brain. 2022;145(3):1079–1097. doi: 10.1093/brain/awab365
   PubMed Web of Science ®Google Scholar